Elevated lysophosphatidic acid levels in the serum and cerebrospinal fluid in patients with multiple sclerosis: therapeutic response and clinical implication

Gintonin, a Ginseng-Derived Lysophosphatidic Acid Receptor Ligand, Attenuates Alzheimer's Disease-Related Neuropathies: Involvement of Non-Amyloidogenic Processing

(2018) Sung Hee Hwang et al.   JOURNAL OF ALZHEIMERS DISEASE

Modulation of Hexadecyl-LPA-Mediated Activation of Mast Cells and Microglia by a Chemical Probe for LPA5

(2016) Detlef H. Kozian et al.   CHEMBIOCHEM

Multiple sclerosis

(2016) Pierre-Paul Axisa et al.   CURRENT OPINION IN NEUROLOGY

Fingolimod promotes peripheral nerve regeneration via modulation of lysophospholipid signaling

(2016) Fabian Szepanowski et al.   Journal of Neuroinflammation

Activation of Lysophosphatidic Acid Receptor Type 1 Contributes to Pathophysiology of Spinal Cord Injury

(2015) E. Santos-Nogueira et al.   JOURNAL OF NEUROSCIENCE

Elevated serum levels of lysophosphatidic acid in patients with multiple sclerosis

(2014) Mohammad Balood et al.   HUMAN IMMUNOLOGY

LPA receptor signaling: pharmacology, physiology, and pathophysiology

(2014) Yun C. Yung et al.   JOURNAL OF LIPID RESEARCH

Increased autotaxin activity in multiple sclerosis

(2014) Hamid Zahednasab et al.   JOURNAL OF NEUROIMMUNOLOGY

Lysophosphatidic acid (LPA) signalling in cell migration and cancer invasion: A focussed review and analysis of LPA receptor gene expression on the basis of more than 1700 cancer microarrays

(2013) Semjon Willier et al.   BIOLOGY OF THE CELL

Rapid and Reversible Enhancement of Blood–Brain Barrier Permeability Using Lysophosphatidic Acid

(2013) Ngoc H On et al.   JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM

Lysophospholipids and their receptors in the central nervous system

(2012) Ji Woong Choi et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Lysoglycerophospholipids in chronic inflammatory disorders: The PLA2/LPC and ATX/LPA axes

(2012) Ioanna Sevastou et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Lysophosphatidic acid: Chemical signature of neuropathic pain

(2012) Hiroshi Ueda et al.   BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR AND CELL BIOLOGY OF LIPIDS

Placebo-Controlled Phase 3 Study of Oral BG-12 for Relapsing Multiple Sclerosis

(2012) Ralf Gold et al.   NEW ENGLAND JOURNAL OF MEDICINE

Diagnostic criteria for multiple sclerosis: 2010 Revisions to the McDonald criteria

(2011) Chris H. Polman et al.   ANNALS OF NEUROLOGY

Modulation of LPA Receptor Expression in the Human Brain Following Neurotrauma

(2011) Tony Frugier et al.   CELLULAR AND MOLECULAR NEUROBIOLOGY

Chemistry and biology of reactive oxygen species in signaling or stress responses

(2011) Bryan C Dickinson et al.   Nature Chemical Biology

Lysophosphatidic Acid Signaling May Initiate Fetal Hydrocephalus

(2011) Y. C. Yung et al.   Science Translational Medicine

Cerebrospinal fluid secretory Ca2+-dependent phospholipase A2 activity: A biomarker of blood–cerebrospinal fluid barrier permeability

(2010) Sonia Chalbot et al.   NEUROSCIENCE LETTERS

Corticosteroids in the treatment of multiple sclerosis

(2009) K. M. Myhr et al.   ACTA NEUROLOGICA SCANDINAVICA

Lysophosphatidic acid (LPA) and its receptors

(2008) Kyoko Noguchi et al.   CURRENT OPINION IN PHARMACOLOGY

Survival and cause of death in multiple sclerosis: results from a 50-year follow-up in Western Norway

(2008) N Grytten Torkildsen et al.   Multiple Sclerosis Journal